中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Huperzine A improves cognitive deficits caused by chronic cerebral hypoperfusion in rats

文献类型:期刊论文

作者Wang, LM; Han, YF; Tang, XC
刊名EUROPEAN JOURNAL OF PHARMACOLOGY
出版日期2000-06-09
卷号398期号:1页码:65-72
关键词(-)-huperzine A acetylcholinesterase cholinesterase inhibitor cerebral ischemia Morris water maze learning memory free radical Alzheimer's disease
ISSN号0014-2999
DOI10.1016/S0014-2999(00)00291-0
文献子类Article
英文摘要The effects of (-)-huperzine A, a promising therapeutic agent for Alzheimer's disease. on learning behavior and on alterations of the cholinergic system, the oxygen free radicals and energy metabolites induced by permanent bilateral Ligation of the common carotid arteries were investigated in rats. Daily oral administration of huperzine A produced a significant improvement of the deficit in the learning of the water maze task, beginning 28 days after ischemia, correlating to about 33-40% inhibition of acetyl-cholinesterase activity in cortex and hippocampus. Huperzine A significantly restored the decrease in choline acetyltransferase activity in hippocampus and significantly reduced the increases in superoxide dismutase, lipid peroxide, lactate and glucose to their normal levels. The present findings demonstrate that the improvement by huperzine A of the cognitive dysfunction in the late phase in chronically hypoperfused rats is due to its effects, not only on the cholinergic system, but also on the oxygen free radical system and energy metabolism. Out results strongly suggest that huperzine A has therapeutic potential for the treatment of dementia caused by cholinergic dysfunction and/or decrease of cerebral blood flow. (C) 2000 Elsevier Science B.V. All rights reserved.
WOS关键词VASCULAR DEMENTIA ; ENERGY-METABOLISM ; WISTAR RATS ; AGED RATS ; BRAIN ; ACETYLCHOLINE ; DYSFUNCTION ; OCCLUSION ; GLUTAMATE ; ISCHEMIA
WOS研究方向Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000087674500008
出版者ELSEVIER SCIENCE BV
源URL[http://119.78.100.183/handle/2S10ELR8/274607]  
专题新药研究国家重点实验室
中科院受体结构与功能重点实验室
通讯作者Tang, XC
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China
2.Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Peoples R China
推荐引用方式
GB/T 7714
Wang, LM,Han, YF,Tang, XC. Huperzine A improves cognitive deficits caused by chronic cerebral hypoperfusion in rats[J]. EUROPEAN JOURNAL OF PHARMACOLOGY,2000,398(1):65-72.
APA Wang, LM,Han, YF,&Tang, XC.(2000).Huperzine A improves cognitive deficits caused by chronic cerebral hypoperfusion in rats.EUROPEAN JOURNAL OF PHARMACOLOGY,398(1),65-72.
MLA Wang, LM,et al."Huperzine A improves cognitive deficits caused by chronic cerebral hypoperfusion in rats".EUROPEAN JOURNAL OF PHARMACOLOGY 398.1(2000):65-72.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。